Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000889812-97-000791
Filing Date
1997-03-26
Accepted
1997-03-26 00:00:00
Documents
9
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 10-K 257321
2 STOCK PURCHASE AGREEMENT EX-10.29 30665
3 REGISTRATION RIGHTS AGREEMENT EX-10.30 34951
4 COLLABORATION AGREEMENT EX-10.31 99255
5 STATEMENT OF COMPUTATION OF LOSS PER SHARE EX-11 2260
6 CONSENT OF INDEPENDENT AUDITORS EX-23.1 847
7 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS EX-23.2 864
8 POWER OF ATTORNEY EX-24 11068
9 FINANCIAL DATA SCHEDULE EX-27 2084
  Complete submission text file 0000889812-97-000791.txt   441513
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 97563989
SIC: 2834 Pharmaceutical Preparations